MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Pfizer Inc.

< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
News headline image
Pfizer Invites Public to View and Listen to Webcast of February 3 Conference Call with Analysts
From Pfizer Inc.
Via Business Wire
Tickers PFE
News headline image
Pfizer Reaffirms Full-Year 2025 EPS Guidance and Provides Full-Year 2026 Guidance
From Pfizer Inc.
Via Business Wire
Tickers PFE
News headline image
Pfizer Declares First-Quarter 2026 Dividend
From Pfizer Inc.
Via Business Wire
Tickers PFE
News headline image
TUKYSA Added to First-Line Maintenance Therapy Extends Median Progression-Free Survival by Over 8 Months in Patients with HER2+ Metastatic Breast Cancer
From Pfizer Inc.
Via Business Wire
Tickers PFE
News headline image
Pfizer Enters into Exclusive Collaboration and License Agreement with YaoPharma
From Pfizer Inc.
Via Business Wire
Tickers PFE
News headline image
HYMPAVZI® (marstacimab) Reduced Bleeds by 93% Compared to On-Demand Treatment in Adults and Adolescents with Hemophilia A or B with Inhibitors
From Pfizer Inc.
Via Business Wire
Tickers PFE
News headline image
Pfizer Invites Public to View and Listen to Webcast of December 16 Conference Call with Analysts to Provide Full-Year 2026 Financial Guidance
From Pfizer Inc.
Via Business Wire
Tickers PFE
News headline image
U.S. FDA Approves PADCEV® plus Keytruda® for Certain Patients with Bladder Cancer
From Pfizer Inc.
Via Business Wire
Tickers PFE
News headline image
Pfizer Completes Acquisition of Metsera
From Pfizer Inc.
Via Business Wire
Tickers PFE
News headline image
Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
From Pfizer Inc.
Via Business Wire
Tickers PFE
News headline image
Pfizer Responds to Delaware Chancery Court Ruling
From Pfizer Inc.
Via Business Wire
Tickers PFE
News headline image
Pfizer Reports Solid Third-Quarter 2025 Results; Raises and Narrows 2025 EPS Guidance
From Pfizer Inc.
Via Business Wire
Tickers PFE
News headline image
Pfizer Files Federal Antitrust Claims in Second Lawsuit Against Metsera, its Controlling Stockholders and Novo Nordisk
From Pfizer Inc.
Via Business Wire
Tickers PFE
News headline image
Pfizer Files Lawsuit Against Metsera and its Directors and Novo Nordisk for Breach of Merger Agreement
From Pfizer Inc.
Via Business Wire
Tickers PFE
News headline image
Pfizer Receives Early Clearance from U.S. Federal Trade Commission for Metsera Acquisition
From Pfizer Inc.
Via Business Wire
Tickers PFE
News headline image
Pfizer Addresses Proposal for Metsera
From Pfizer Inc.
Via Business Wire
Tickers PFE
News headline image
XTANDI® Plus Leuprolide Reduced Risk of Death by 40% vs Leuprolide Alone in Men with a Type of Advanced Prostate Cancer
From Pfizer Inc.
Via Business Wire
Tickers PFE
News headline image
Pfizer’s BRAFTOVI® + MEKTOVI® Shows Sustained Long-Term Survival in Patients with Advanced Lung Cancer
From Pfizer Inc.
Via Business Wire
Tickers PFE
News headline image
TUKYSA Combination Significantly Improves Progression-Free Survival as First-Line Maintenance in HER2+ Metastatic Breast Cancer in HER2CLIMB-05 Trial
From Pfizer Inc.
Via Business Wire
Tickers PFE
News headline image
Pfizer to Highlight Advancements in Respiratory Health and Infectious Disease Research at IDWeek 2025
From Pfizer Inc.
Via Business Wire
Tickers PFE
News headline image
Pfizer Declares Fourth-Quarter 2025 Dividend
From Pfizer Inc.
Via Business Wire
Tickers PFE
News headline image
Pfizer Reaches Landmark Agreement with U.S. Government to Lower Drug Costs for American Patients
From Pfizer Inc.
Via Business Wire
Tickers PFE
News headline image
Pfizer Highlights Momentum in Redefining Standards of Care in Cancer at ESMO 2025
From Pfizer Inc.
Via Business Wire
Tickers PFE
News headline image
Pfizer Invites Public to View and Listen to Webcast of November 4 Conference Call with Analysts
From Pfizer Inc.
Via Business Wire
Tickers PFE
News headline image
Pfizer to Acquire Metsera and its Next-Generation Obesity Portfolio
From Pfizer Inc.
Via Business Wire
Tickers MTSR PFE
News headline image
Pfizer and BioNTech Announce Topline Data Demonstrating Robust Immune Response With Their LP.8.1-Adapted COVID-19 Vaccine 2025-2026 Formula
From Pfizer Inc.
Via Business Wire
Tickers BNTX PFE
News headline image
Pfizer and BioNTech’s COMIRNATY® Receives U.S. FDA Approval for Adults 65 and Older and Individuals Ages 5 through 64 at Increased Risk for Severe COVID-19
From Pfizer Inc.
Via Business Wire
Tickers BNTX PFE
News headline image
PADCEV™ Plus KEYTRUDA™ Significantly Improves Survival for Certain Patients with Bladder Cancer When Given Before and After Surgery
From Pfizer Inc.
Via Business Wire
Tickers PFE
News headline image
Pfizer Reports Strong Second-Quarter 2025 Results And Raises 2025 EPS Guidance
From Pfizer Inc.
Via Business Wire
Tickers PFE
News headline image
Pfizer and BioNTech Receive Positive CHMP Opinion for LP.8.1-adapted COVID-19 Vaccine in the European Union
From Pfizer Inc.
Via Business Wire
Tickers BNTX PFE
< Previous 1 2 3 4 5 6 7 8 9
...
11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story